EP: 3.Evaluating the Role of Surgery in Mesothelioma: The MARS2 Trial Now Viewing EP: 4.EVOKE-02: Sacituzumab Govitecan + Pembrolizumab in Non–Small Cell Lung Cancer EP: 5.Closing Thoughts on Data Updates From IASLC 2023 World Conference on Lung Cancer ...
EP: 7.Clinical Trial Data on Sacituzumab Govitecan in NSCLC Now Viewing EP: 8.EVOKE-02: Sacituzumab Govitecan Plus Pembrolizumab in First-Line Metastatic NSCLC EP: 9.Advanced NSCLC: TROPION-Lung02 and TROPION-Lung04 EP: 10.Antibody-Drug Conjugate Safety Profiles in NSCLC EP: 11...
● Thank you to the clinical trial investigators and their team members, without whom this work would not have been possible 13
This study is open for recruitment and is enrolling globally.Clinical trial information: NCT05186974.Edward B. GaronRonald Reagan UCLA Medical Center, Santa Monica, CA;Stephen V. LiuLombardi Comprehensive Cancer Center, Georgetown University, Washington, DC;Scott Peter Owen...
随着生物科学技术的进步,各种类型创新疗法不断涌现并在临床研究得到验证,展现出了巨大的临床潜力。新技术、新靶点药物的早期临床研究与注册性临床研究(Pivotal Trial)的价值在整个药物研发中日益显著。其中,试验结果对于适应症拓展与后续研究的方案制定具有举足轻重的作用,因而对结果的解读很有必要。
The trials will provide data on the potential disease-modifying effects of semaglutide and will be important in evaluating its utility in the treatment of early-stage symptomatic AD. Trial registration Clinicaltrials.gov, NCT04777396 and NCT04777409. Date: 02/03/2021...
The EVOKE-03 study (NCT05609968) of pembro vs SG + pembro in mNSCLC is ongoing.Clinical trial information: NCT05186974.Summary of combination SG + pembro efficacy in mNSCLC (Cohort A).Overall (n=30)Squamous (n=12)Nonsquamous (n=18)ORR (CR+PR), n (% [95% CI])20 (67 [47-83])...
Gilead plans to discuss results from this trial with regulators. The data will be presented at an upcoming medical meeting. “The totality of our data gives us continued confidence in Trodelvy’s potential in metastatic NSCLC, and in our broader lung cancer clinical development program,” said ...
Communications strategies to take your trial from first patient dosed to fully enrolled, including branding, website, media outreach, and content to raise awareness and engagement with patients and physicians. Internal & Employee Comms Powerful campaigns that highlight your purpose and culture to attrac...
Replication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trial. Biol Psychiatry 2012; 71: 939–946. Google Scholar Drevets WC, Price JL, Simpson JR Jr, Todd RD, Reich T, Vannier M et al. Subgenual prefrontal cortex abnormalities in mood ...